XML 49 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
ASSETS IMPAIRMENTS AND RESTRUCTURING (Tables)
9 Months Ended
Sep. 30, 2022
Restructuring Costs and Asset Impairment Charges [Abstract]  
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]
The following table summarizes the changes in asset impairments and restructuring reserves in first nine months 2022 and full year 2021:

(Dollars in millions)Balance at January 1, 2022Provision/ AdjustmentsNon-cash Reductions/
Additions
Cash ReductionsBalance at September 30, 2022
Severance costs$12 $$— $(8)$
Other restructuring costs20 (7)19 
Total$17 $23 $$(15)$26 

(Dollars in millions)
Balance at January 1, 2021Provision/ AdjustmentsNon-cash Reductions/
Additions
Cash ReductionsBalance at December 31, 2021
Non-cash charges$— $16 $(16)$— $— 
Severance costs65 (1)(54)12 
Other restructuring costs14 29 (9)(29)
Total$79 $47 $(26)$(83)$17 
Restructuring and Related Costs [Table Text Block]
(Dollars in millions)Third QuarterFirst Nine Months
Tangible Asset Impairments2022202120222021
Site optimizations
Other - Tire additives (1)
$— $— $— $
AM - Advanced interlayers (2)
— — — 
— — — 
Loss (Gain) on Sale of Previously Impaired Assets
Site optimizations
Other - Tire additives (1)
— — (1)— 
AM - Advanced interlayers (2)
— — 16 — 
AFP - Animal nutrition (3)
— — — (1)
— — 15 (1)
Severance Charges
Business improvement and cost reduction actions (4)
— — — 
Site optimizations
AM - Performance films (5)
— — — 
AM - Advanced interlayers (2)
— — — 
— — 
Other Restructuring Costs
CI & AFP - Singapore (6)
16 
Site optimizations
AM - Advanced interlayers (2)
AM - Performance films (5)
— — 
Other - Tire additives (1)
— — 
24 
Total$$$23 $29 

(1)Asset impairment charges, gain on sale of previously impaired assets, and site closure costs in "Other" from the previously reported closure of a tire additives manufacturing facility in Asia Pacific as part of ongoing site optimization.
(2)Asset impairment charges, loss on transfer of previously impaired assets to a third party, severance costs, and site closure costs in the Advanced Materials ("AM") segment due to the previously reported closure of an advanced interlayers manufacturing facility in North America as part of ongoing site optimization. In addition, accelerated depreciation of $4 million was recognized in "Cost of sales" in the Unaudited Consolidated Statements of Earnings, Comprehensive Income and Retained Earnings in first nine months 2021 related to the closure of this facility.
(3)Fixed asset impairments, net in the AFP segment from the previously reported closure of an animal nutrition manufacturing facility in Asia Pacific as part of ongoing site optimization.
(4)Severance charges as part of business improvement which was reported in "Other".
(5)Severance charges and site closure costs in the AM segment from the previously reported closure of a performance films manufacturing facility in North America as part of ongoing site optimization.
(6)Site closure costs of $1 million and $3 million for third quarter and first nine months 2022, respectively, in the Chemical Intermediates ("CI") segment. Site closure costs in third quarter 2021 of $2 million and $1 million in the CI and AFP segments, respectively, and site closure costs, including contract termination fees, in first nine months 2021 of $13 million and $3 million in the CI and AFP segments, respectively, resulting from closure of the Singapore manufacturing site.